Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

SELL
$8.4 - $28.4 $45,292 - $153,132
-5,392 Reduced 0.24%
2,287,892 $20.1 Million
Q2 2022

Aug 12, 2022

SELL
$10.78 - $15.5 $59,527 - $85,591
-5,522 Reduced 0.24%
2,293,284 $27.5 Million
Q1 2022

May 13, 2022

BUY
$12.93 - $23.46 $829,886 - $1.51 Million
64,183 Added 2.87%
2,298,806 $34.8 Million
Q4 2021

Feb 11, 2022

BUY
$22.0 - $25.77 $49.2 Million - $57.6 Million
2,234,623 New
2,234,623 $53.1 Million

Others Institutions Holding EVO

About Evotec SE


  • Ticker EVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 353,904,992
  • Market Cap $1.68B
  • Description
  • Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare di...
More about EVO
Track This Portfolio

Track Artisan Partners Limited Partnership Portfolio

Follow Artisan Partners Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artisan Partners Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Artisan Partners Limited Partnership with notifications on news.